News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SNODGRASS H. RALPH
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/03/2022 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 3,623 shares
@ $1.6575, valued at
$6k
|
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2020 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.398, valued at
$59.7k
|
|
| 11/21/2019 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Bought 15,000 shares
@ $0.34, valued at
$5.1k
|
|
| 10/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2019 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1, valued at
$150k
|
|
| 03/14/2019 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Exercised 2,500 options to buy
@ $1.5, valued at
$3.8k
|
|
| 08/31/2018 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Disposed/sold 2,500 options to buy
@ $10, valued at
$25k
Granted 2,500 options to buy
@ $1.5, valued at
$3.8k
Disposed/sold 1,250 options to buy
@ $10, valued at
$12.5k
Granted 1,250 options to buy
@ $1.5, valued at
$1.9k
Disposed/sold 12,500 options to buy
@ $10, valued at
$125k
Granted 12,500 options to buy
@ $1.5, valued at
$18.8k
Disposed/sold 125,000 options to buy
@ $3.49, valued at
$436.3k
Granted 125,000 options to buy
@ $1.5, valued at
$187.5k
Disposed/sold 80,000 options to buy
@ $3.8, valued at
$304k
Granted 80,000 options to buy
@ $1.5, valued at
$120k
Disposed/sold 125,000 options to buy
@ $1.96, valued at
$245k
|
|
| 08/06/2018 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.27, valued at
$158.8k
|
|
| 02/05/2018 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 175,000 options to buy
@ $1.16, valued at
$203k
|
|
| 09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/10/2016 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $3.8, valued at
$304k
|
|
| 06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/13/2015 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Disposed/sold 50,000 options to buy
@ $12.8, valued at
$640k
Granted 50,000 options to buy
@ $7, valued at
$350k
Disposed/sold 2,500 options to buy
@ $10, valued at
$25k
Granted 2,500 options to buy
@ $7, valued at
$17.5k
Disposed/sold 7,500 options to buy
@ $10, valued at
$75k
Granted 7,500 options to buy
@ $7, valued at
$52.5k
Disposed/sold 100,000 options to buy
@ $10, valued at
$1M
Granted 100,000 options to buy
@ $7, valued at
$700k
Disposed/sold 150,000 options to buy
@ $9.25, valued at
$1.4M
Granted 150,000 options to buy
@ $7, valued at
$1.1M
|
|
| 09/03/2015 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $9.25, valued at
$1.4M
|
|
| 01/13/2015 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $10, valued at
$1M
|
|
| 03/21/2014 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Acquired 50,000 warrants
@ $0.5, valued at
$25k
Acquired 150,000 warrants
@ $0.5, valued at
$75k
|
|
| 12/24/2013 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Disposed/sold 50,000 options to buy
@ $1.13, valued at
$56.5k
Granted 50,000 options to buy
@ $0.5, valued at
$25k
Disposed/sold 25,000 options to buy
@ $1.13, valued at
$28.3k
Granted 25,000 options to buy
@ $0.5, valued at
$12.5k
Disposed/sold 150,000 options to buy
@ $1.65, valued at
$247.5k
Granted 150,000 options to buy
@ $0.5, valued at
$75k
Disposed/sold 250,000 options to buy
@ $1.5, valued at
$375k
Granted 250,000 options to buy
@ $0.5, valued at
$125k
Disposed/sold 100,000 options to buy
@ $1.93, valued at
$193k
Granted 100,000 options to buy
@ $0.5, valued at
$50k
|
|
| 03/05/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2011 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Exercised 113,636 shares
@ $0.88, valued at
$100k
Exercised 113,636 options to buy
@ $0 |
|
| 05/25/2011 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Excaliber Enterprises, Ltd.|
Txns:
| Granted 545,416 shares
@ $3.5, valued at
$1.9M
Granted 56,818 options to buy
@ $1.76, valued at
$100k
Granted 3,181 options to buy
@ $1.76, valued at
$5.6k
Granted 20,000 options to buy
@ $1.58, valued at
$31.6k
Granted 12,500 options to buy
@ $4.62, valued at
$57.8k
Granted 25,000 options to buy
@ $2.26, valued at
$56.5k
Granted 12,500 options to buy
@ $2.26, valued at
$28.3k
Granted 75,000 options to buy
@ $3, valued at
$225k
Granted 125,000 options to buy
@ $3, valued at
$375k
Granted 50,000 options to buy
@ $3.85, valued at
$192.5k
|
|
|
|